Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedThe listing now identifies ovarian cancer as the condition, links related topics, and updates the study's location count to 6 locations with milestone dates such as 2026-07-14 and 2026-12-31. Additionally, outdated contact details and a Montreal location entry were removed, accompanying a change in reported locations from 7 to 6 and a revised recruitment status.SummaryDifference0.8%

- Check12 days agoChange DetectedThe page no longer lists 'Ovarian cancer' under related topics and the MedlinePlus Genetics link in the related resources. This reduces disease-focused context and access to consumer health information on ovarian cancer.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page shows a new revision label v3.6.3 replacing the previous v3.6.2, indicating a small, non-content related update to the page.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page shows a new revision label: v3.6.2 replacing the previous v3.6.0. This indicates a new build of the page.SummaryDifference0.0%

- Check41 days agoChange DetectedNew quick links were added to the page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) along with a new revision tag 'Revision: v3.6.0'. The 'Intervention / Treatment' heading formatting was updated to align with updated terminology.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page revision label updated from v3.5.4 to v3.5.5, signaling a minor update to the study record's content or metadata. This reflects an update to the page's versioning and does not imply a change to the study's details.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.